A phase I study of TS-1 and docetaxel for advanced gastric cancer
Not Applicable
Suspended
- Conditions
- advanced gastric cancer
- Registration Number
- JPRN-C000000188
- Lead Sponsor
- Department of Medical Oncology, Kinki University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of active other malignancy 2) Severe heart disease (uncontrolled angina pectoris,myocardial infarction,heart failure within 3 months 3) Uncontrolled diabetes and hypertension 4) Severe complication (infection, bowel obstruction,or hemorrhage etc.) 5) > G2 neuropathy 6) Massive pleural,cardiac,or abdominal effusion 7) Intestinal fresh hemorrhage 8) Symptomatic brain metastasis 9) Pregnant women or women willing child-bearing 10) History of severe drug allergic reaction 11) Limitation of use of TS1 or docetaxel 12) Inadequate condition diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method